Brandes Investment Partners, LP Avadel Pharmaceuticals PLC Transaction History

Brandes Investment Partners, LP

$8.37 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$12.55 - $17.22 $895,931 - $1.23 Million	-71,389 Reduced 4.65%	1,462,225 $24.7 Million
Q4 2023 Feb 09, 2024	BUY	$9.64 - $14.59 $817,876 - $1.24 Million	84,842 Added 5.86%	1,533,614 $21.7 Million
Q3 2023 Nov 13, 2023	BUY	$10.3 - $15.99 $1.64 Million - $2.55 Million	159,577 Added 12.38%	1,448,772 $14.9 Million
Q2 2023 Aug 11, 2023	SELL	$8.48 - $16.48 $1.32 Million - $2.56 Million	-155,440 Reduced 10.76%	1,289,195 $21.2 Million
Q1 2023 May 10, 2023	SELL	$6.41 - $9.95 $1.35 Million - $2.1 Million	-210,625 Reduced 12.72%	1,444,635 $13.2 Million
Q4 2022 Feb 13, 2023	SELL	$5.02 - $10.0 $5.24 Million - $10.4 Million	-1,044,535 Reduced 38.69%	1,655,260 $11.9 Million
Q3 2022 Nov 14, 2022	SELL	$2.57 - $7.31 $2.39 Million - $6.81 Million	-931,680 Reduced 25.66%	2,699,795 $13.5 Million
Q2 2022 Aug 12, 2022	BUY	$1.07 - $6.95 $687,796 - $4.47 Million	642,800 Added 21.51%	3,631,475 $8.86 Million
Q1 2022 May 10, 2022	BUY	$5.46 - $8.29 $2.12 Million - $3.23 Million	389,041 Added 14.97%	2,988,675 $20.4 Million
Q4 2021 Feb 11, 2022	SELL	$7.34 - $11.18 $4.75 Million - $7.24 Million	-647,652 Reduced 19.94%	2,599,634 $21 Million
Q3 2021 Nov 12, 2021	BUY	$6.49 - $9.91 $47,214 - $72,095	7,275 Added 0.22%	3,247,286 $31.8 Million
Q2 2021 Aug 11, 2021	BUY	$6.73 - $9.05 $2.06 Million - $2.77 Million	305,770 Added 10.42%	3,240,011 $21.8 Million
Q1 2021 May 14, 2021	SELL	$6.61 - $10.07 $182,680 - $278,304	-27,637 Reduced 0.93%	2,934,241 $26 Million
Q4 2020 Feb 11, 2021	BUY	$5.03 - $7.95 $609,681 - $963,611	121,209 Added 4.27%	2,961,878 $19.8 Million
Q3 2020 Nov 12, 2020	BUY	$5.02 - $8.98 $6.81 Million - $12.2 Million	1,357,042 Added 91.47%	2,840,669 $14.3 Million
Q2 2020 Aug 12, 2020	SELL	$7.25 - $11.75 $1.13 Million - $1.82 Million	-155,211 Reduced 9.47%	1,483,627 $12 Million
Q1 2020 May 13, 2020	SELL	$4.06 - $10.64 $8.17 Million - $21.4 Million	-2,013,110 Reduced 55.12%	1,638,838 $13 Million
Q4 2019 Feb 13, 2020	SELL	$3.34 - $7.7 $8.45 Million - $19.5 Million	-2,530,888 Reduced 40.93%	3,651,948 $27.6 Million
Q3 2019 Nov 13, 2019	SELL	$1.92 - $4.47 $1.16 Million - $2.69 Million	-601,954 Reduced 8.87%	6,182,836 $25.7 Million
Q2 2019 Aug 13, 2019	SELL	$1.09 - $3.19 $292,043 - $854,696	-267,930 Reduced 3.8%	6,784,790 $19.6 Million
Q1 2019 May 10, 2019	SELL	$1.44 - $3.29 $95,520 - $218,238	-66,334 Reduced 0.93%	7,052,720 $10.2 Million
Q4 2018 Feb 11, 2019	BUY	$1.74 - $4.66 $1.36 Million - $3.65 Million	783,506 Added 12.37%	7,119,054 $18.4 Million
Q3 2018 Nov 09, 2018	BUY	$4.08 - $7.14 $5.57 Million - $9.75 Million	1,365,442 Added 27.47%	6,335,548 $27.8 Million
Q2 2018 Aug 13, 2018	BUY	$5.89 - $7.78 $951,900 - $1.26 Million	161,613 Added 3.36%	4,970,106 $30.5 Million
Q1 2018 May 15, 2018	BUY	$6.76 - $11.7 $10.1 Million - $17.6 Million	1,500,243 Added 45.35%	4,808,493 $35.1 Million
Q4 2017 Feb 12, 2018	BUY	$8.03 - $11.25 $26.6 Million - $37.2 Million	3,308,250	3,308,250 $27.1 Million

Others Institutions Holding AVDL

# of Institutions

Shares Held

1.07M

Call Options Held

Put Options Held

View Full List

About AVADEL PHARMACEUTICALS PLC

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $650M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

More about AVDL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandes Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Brandes Investment Partners, LP with notifications on news.

Account